Baker Avenue Asset Management, LP Jazz Pharmaceuticals PLC Transaction History

Baker Avenue Asset Management, LP

  • $3.41 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$133.98 - $160.47 $1,607 - $1,925
-12 Reduced 54.55%
10 $1,000
Q4 2022

Feb 13, 2023
BUY
$129.72 - $159.85 $2,853 - $3,516
22 New
22 $3,000
Q1 2020

May 14, 2020
SELL
$87.74 - $152.74 $131,610 - $229,110
-1,500 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$117.65 - $153.73 $176,475 - $230,594
1,500 New
1,500 $223,000

Others Institutions Holding JAZZ

# of Institutions
512
Shares Held
57.5M
Call Options Held
188K
Put Options Held
133K
View Full List

About Jazz Pharmaceuticals plc

JAZZ Quotes by TradingView
  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Baker Avenue Asset Management, LP Portfolio

Follow Baker Avenue Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Avenue Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Baker Avenue Asset Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email